| SS-Chr 12BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
10 |
|
11.18 |
ml/min/g |
0.54 |
1.72 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46674 |
461 |
| SS-Chr 12BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
10 |
|
4.18 |
ml/min/g |
0.39 |
1.24 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
44743 |
461 |
| SS-Chr 12BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
10 |
|
9.63 |
ml/min/g |
0.51 |
1.62 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46895 |
461 |
| SS-Chr 12BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
51.91 |
% |
3.03 |
9.1 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46091 |
461 |
| SS-Chr 12BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
41.21 |
% |
3.77 |
10.67 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46087 |
461 |
| SS-Chr 12BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
42.29 |
% |
3.17 |
10.03 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47102 |
461 |
| SS-Chr 12BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49.0 days-63.0 days |
9 |
|
0.28 |
IU/g |
0.07 |
0.2 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47496 |
461 |
| SS-Chr 12BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49.0 days-63.0 days |
10 |
|
12.57 |
IU/g |
2.32 |
7.35 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46004 |
461 |
| SS-Chr 12BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
8 |
|
3.36 |
ml/min/g |
0.28 |
0.78 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46222 |
461 |
| SS-Chr 12BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
9 |
|
8.36 |
ml/min/g |
0.5 |
1.49 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46891 |
461 |
| SS-Chr 12BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49.0 days-63.0 days |
2 |
|
0.22 |
IU/g |
0.04 |
0.06 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47504 |
461 |
| SS-Chr 12BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
10 |
|
10.03 |
ml/min/g |
0.8 |
2.53 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46678 |
461 |
| SS-Chr 12BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49.0 days-63.0 days |
7 |
|
8.76 |
IU/g |
1.36 |
3.61 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46010 |
461 |
| SS-Chr 12BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
10 |
|
5.09 |
ml/min/g |
0.54 |
1.71 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
44739 |
461 |
| SS-Chr 12BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
45.22 |
% |
3.81 |
12.06 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47098 |
461 |
| SS-Chr 12BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
9 |
|
5.16 |
ml/min/g |
0.48 |
1.44 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46226 |
461 |